Austin Stevenson Bio

Austin Stevenson is Chief Revenue Officer of ACT LAB, a private equity-backed, multistate testing and compliance laboratory network operating at the intersection of life sciences, natural products, consumer health, and regulated product markets, including cannabis.

Stevenson specializes in scaling businesses through critical inflection points: transforming high-growth platforms into disciplined, acquisition-ready organizations. At ACT LAB, he leads national commercial strategy and market expansion, helping drive growth across key U.S. markets while aligning the business for scale and future acquisition opportunities.

His career has been defined by bridging scientific innovation with real-world commercialization. Stevenson has helped bring emerging product categories from concept to scale in highly regulated environments, enabling operators to navigate complexity, reduce risk, and accelerate time to market.

As cofounder of Vertosa, he pioneered emulsion technologies that made cannabis-infused beverages and edibles commercially viable at scale. At Eurofins Scientific, he developed expertise in global quality systems, laboratory operations, and regulated product testing—experience he now applies to building standardized, multi-market testing infrastructure.

At ACT LAB, Stevenson is focused on expanding the role of laboratory science beyond compliance. By translating complex testing data into clear, actionable insights, he helps operators make better decisions across product development, supply chain management, and commercialization. His work has supported thousands of products and brands navigating evolving regulatory frameworks while improving consistency, accuracy, and consumer trust.

Under his leadership, ACT LAB is evolving into a next-generation testing platform—expanding nationally, preparing to enter international markets, and extending its capabilities into nutraceutical and pharmaceutical-adjacent categories. By applying pharmaceutical-grade rigor to emerging consumer products, Stevenson is helping build the infrastructure required for regulated industries to scale safely, credibly, and efficiently.

Stevenson is recognized for his ability to make complex science accessible and commercially relevant, bridging the gap between laboratory precision and real-world business outcomes. Stevenson is a Forbes Cannabis 42.0 honoree and a San Francisco Business Times 40 Under 40 award recipient.